nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrazepam—GABRA3—Graves' disease	0.712	1	CbGaD
Nitrazepam—CYP2E1—Methimazole—Graves' disease	0.116	0.767	CbGbCtD
Nitrazepam—CYP3A4—Methimazole—Graves' disease	0.0351	0.233	CbGbCtD
Nitrazepam—GABRQ—GABA A receptor activation—GABRA3—Graves' disease	0.00421	0.0406	CbGpPWpGaD
Nitrazepam—GABRG3—GABA A receptor activation—GABRA3—Graves' disease	0.00347	0.0334	CbGpPWpGaD
Nitrazepam—GABRB1—GABA A receptor activation—GABRA3—Graves' disease	0.00342	0.0329	CbGpPWpGaD
Nitrazepam—GABRA6—GABA A receptor activation—GABRA3—Graves' disease	0.00323	0.0311	CbGpPWpGaD
Nitrazepam—GABRA4—GABA A receptor activation—GABRA3—Graves' disease	0.00319	0.0307	CbGpPWpGaD
Nitrazepam—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.00292	0.0281	CbGpPWpGaD
Nitrazepam—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.00284	0.0273	CbGpPWpGaD
Nitrazepam—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00274	0.0264	CbGpPWpGaD
Nitrazepam—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.00272	0.0262	CbGpPWpGaD
Nitrazepam—GABRR1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0027	0.026	CbGpPWpGaD
Nitrazepam—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00267	0.0257	CbGpPWpGaD
Nitrazepam—GABRQ—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00258	0.0248	CbGpPWpGaD
Nitrazepam—GABRR2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00258	0.0248	CbGpPWpGaD
Nitrazepam—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.00234	0.0225	CbGpPWpGaD
Nitrazepam—GABRG3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00212	0.0205	CbGpPWpGaD
Nitrazepam—GABRB1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00209	0.0201	CbGpPWpGaD
Nitrazepam—GABRA6—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00198	0.0191	CbGpPWpGaD
Nitrazepam—GABRA4—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00196	0.0188	CbGpPWpGaD
Nitrazepam—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00179	0.0172	CbGpPWpGaD
Nitrazepam—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00174	0.0167	CbGpPWpGaD
Nitrazepam—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00168	0.0161	CbGpPWpGaD
Nitrazepam—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00167	0.016	CbGpPWpGaD
Nitrazepam—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00164	0.0157	CbGpPWpGaD
Nitrazepam—GABRR1—GABA receptor activation—GABRA3—Graves' disease	0.00144	0.0138	CbGpPWpGaD
Nitrazepam—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00143	0.0138	CbGpPWpGaD
Nitrazepam—GABRQ—GABA receptor activation—GABRA3—Graves' disease	0.00137	0.0132	CbGpPWpGaD
Nitrazepam—GABRR2—GABA receptor activation—GABRA3—Graves' disease	0.00137	0.0132	CbGpPWpGaD
Nitrazepam—Drowsiness—Methimazole—Graves' disease	0.00121	0.064	CcSEcCtD
Nitrazepam—Jaundice—Methimazole—Graves' disease	0.00118	0.0623	CcSEcCtD
Nitrazepam—Agranulocytosis—Methimazole—Graves' disease	0.00113	0.0597	CcSEcCtD
Nitrazepam—GABRG3—GABA receptor activation—GABRA3—Graves' disease	0.00113	0.0109	CbGpPWpGaD
Nitrazepam—GABRB1—GABA receptor activation—GABRA3—Graves' disease	0.00111	0.0107	CbGpPWpGaD
Nitrazepam—GABRA6—GABA receptor activation—GABRA3—Graves' disease	0.00105	0.0101	CbGpPWpGaD
Nitrazepam—GABRA4—GABA receptor activation—GABRA3—Graves' disease	0.00104	0.00999	CbGpPWpGaD
Nitrazepam—Drowsiness—Propylthiouracil—Graves' disease	0.00103	0.0544	CcSEcCtD
Nitrazepam—Jaundice—Propylthiouracil—Graves' disease	0.001	0.053	CcSEcCtD
Nitrazepam—Agranulocytosis—Propylthiouracil—Graves' disease	0.000961	0.0507	CcSEcCtD
Nitrazepam—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.000949	0.00914	CbGpPWpGaD
Nitrazepam—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.000922	0.00887	CbGpPWpGaD
Nitrazepam—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.00089	0.00856	CbGpPWpGaD
Nitrazepam—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.000884	0.00851	CbGpPWpGaD
Nitrazepam—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.000868	0.00836	CbGpPWpGaD
Nitrazepam—GABRR3—eye—Graves' disease	0.000856	0.116	CbGeAlD
Nitrazepam—Vertigo—Methimazole—Graves' disease	0.000851	0.0449	CcSEcCtD
Nitrazepam—Leukopenia—Methimazole—Graves' disease	0.000847	0.0447	CcSEcCtD
Nitrazepam—GABRQ—Orphan transporters—GABRA3—Graves' disease	0.000798	0.00769	CbGpPWpGaD
Nitrazepam—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.000759	0.0073	CbGpPWpGaD
Nitrazepam—GABRR2—eye—Graves' disease	0.000742	0.1	CbGeAlD
Nitrazepam—Vertigo—Propylthiouracil—Graves' disease	0.000723	0.0382	CcSEcCtD
Nitrazepam—Leukopenia—Propylthiouracil—Graves' disease	0.000721	0.038	CcSEcCtD
Nitrazepam—GABRR1—eye—Graves' disease	0.000714	0.0966	CbGeAlD
Nitrazepam—Bromazepam—GABRA3—Graves' disease	0.000698	0.0961	CrCbGaD
Nitrazepam—Paraesthesia—Methimazole—Graves' disease	0.000694	0.0366	CcSEcCtD
Nitrazepam—Somnolence—Methimazole—Graves' disease	0.000687	0.0363	CcSEcCtD
Nitrazepam—Dyspepsia—Methimazole—Graves' disease	0.00068	0.0359	CcSEcCtD
Nitrazepam—Chlordiazepoxide—GABRA3—Graves' disease	0.000678	0.0933	CrCbGaD
Nitrazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00066	0.00635	CbGpPWpGaD
Nitrazepam—GABRG3—Orphan transporters—GABRA3—Graves' disease	0.000657	0.00633	CbGpPWpGaD
Nitrazepam—Clonazepam—GABRA3—Graves' disease	0.000655	0.0901	CrCbGaD
Nitrazepam—GABRB1—Orphan transporters—GABRA3—Graves' disease	0.000648	0.00623	CbGpPWpGaD
Nitrazepam—Clorazepate—GABRA3—Graves' disease	0.000634	0.0873	CrCbGaD
Nitrazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000629	0.00606	CbGpPWpGaD
Nitrazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000629	0.00606	CbGpPWpGaD
Nitrazepam—GABRA6—Orphan transporters—GABRA3—Graves' disease	0.000613	0.0059	CbGpPWpGaD
Nitrazepam—GABRA4—Orphan transporters—GABRA3—Graves' disease	0.000605	0.00582	CbGpPWpGaD
Nitrazepam—Paraesthesia—Propylthiouracil—Graves' disease	0.00059	0.0311	CcSEcCtD
Nitrazepam—GABRR1—Ion channel transport—GABRA3—Graves' disease	0.000587	0.00565	CbGpPWpGaD
Nitrazepam—Somnolence—Propylthiouracil—Graves' disease	0.000584	0.0308	CcSEcCtD
Nitrazepam—Dyspepsia—Propylthiouracil—Graves' disease	0.000578	0.0305	CcSEcCtD
Nitrazepam—Alprazolam—GABRA3—Graves' disease	0.000574	0.079	CrCbGaD
Nitrazepam—GABRQ—Ion channel transport—GABRA3—Graves' disease	0.00056	0.00539	CbGpPWpGaD
Nitrazepam—GABRR2—Ion channel transport—GABRA3—Graves' disease	0.00056	0.00539	CbGpPWpGaD
Nitrazepam—GABRG3—pituitary gland—Graves' disease	0.000556	0.0752	CbGeAlD
Nitrazepam—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.000553	0.00533	CbGpPWpGaD
Nitrazepam—Pruritus—Methimazole—Graves' disease	0.000547	0.0289	CcSEcCtD
Nitrazepam—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.000538	0.00518	CbGpPWpGaD
Nitrazepam—Flunitrazepam—GABRA3—Graves' disease	0.000526	0.0723	CrCbGaD
Nitrazepam—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.000519	0.00499	CbGpPWpGaD
Nitrazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000518	0.00499	CbGpPWpGaD
Nitrazepam—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.000515	0.00496	CbGpPWpGaD
Nitrazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000511	0.00491	CbGpPWpGaD
Nitrazepam—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000506	0.00487	CbGpPWpGaD
Nitrazepam—GABRR1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000496	0.00477	CbGpPWpGaD
Nitrazepam—Estazolam—GABRA3—Graves' disease	0.000492	0.0677	CrCbGaD
Nitrazepam—Vomiting—Methimazole—Graves' disease	0.000491	0.0259	CcSEcCtD
Nitrazepam—Rash—Methimazole—Graves' disease	0.000487	0.0257	CcSEcCtD
Nitrazepam—Dermatitis—Methimazole—Graves' disease	0.000487	0.0257	CcSEcCtD
Nitrazepam—Headache—Methimazole—Graves' disease	0.000484	0.0256	CcSEcCtD
Nitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000483	0.00465	CbGpPWpGaD
Nitrazepam—Halazepam—GABRA3—Graves' disease	0.000478	0.0657	CrCbGaD
Nitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000477	0.00459	CbGpPWpGaD
Nitrazepam—GABRQ—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000473	0.00455	CbGpPWpGaD
Nitrazepam—GABRR2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000473	0.00455	CbGpPWpGaD
Nitrazepam—Adinazolam—GABRA3—Graves' disease	0.000468	0.0644	CrCbGaD
Nitrazepam—Pruritus—Propylthiouracil—Graves' disease	0.000465	0.0245	CcSEcCtD
Nitrazepam—Fludiazepam—GABRA3—Graves' disease	0.000464	0.0638	CrCbGaD
Nitrazepam—GABRG3—Ion channel transport—GABRA3—Graves' disease	0.000461	0.00444	CbGpPWpGaD
Nitrazepam—Nausea—Methimazole—Graves' disease	0.000459	0.0242	CcSEcCtD
Nitrazepam—GABRB1—Ion channel transport—GABRA3—Graves' disease	0.000454	0.00437	CbGpPWpGaD
Nitrazepam—Prazepam—GABRA3—Graves' disease	0.000453	0.0623	CrCbGaD
Nitrazepam—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.000442	0.00426	CbGpPWpGaD
Nitrazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000436	0.0042	CbGpPWpGaD
Nitrazepam—GABRB1—pituitary gland—Graves' disease	0.00043	0.0582	CbGeAlD
Nitrazepam—GABRA6—Ion channel transport—GABRA3—Graves' disease	0.00043	0.00414	CbGpPWpGaD
Nitrazepam—GABRA4—Ion channel transport—GABRA3—Graves' disease	0.000424	0.00409	CbGpPWpGaD
Nitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000424	0.00408	CbGpPWpGaD
Nitrazepam—Vomiting—Propylthiouracil—Graves' disease	0.000418	0.0221	CcSEcCtD
Nitrazepam—Rash—Propylthiouracil—Graves' disease	0.000414	0.0219	CcSEcCtD
Nitrazepam—Dermatitis—Propylthiouracil—Graves' disease	0.000414	0.0218	CcSEcCtD
Nitrazepam—Headache—Propylthiouracil—Graves' disease	0.000412	0.0217	CcSEcCtD
Nitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000409	0.00394	CbGpPWpGaD
Nitrazepam—Oxazepam—GABRA3—Graves' disease	0.000409	0.0562	CrCbGaD
Nitrazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000406	0.00391	CbGpPWpGaD
Nitrazepam—Temazepam—GABRA3—Graves' disease	0.000404	0.0555	CrCbGaD
Nitrazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000399	0.00384	CbGpPWpGaD
Nitrazepam—Nausea—Propylthiouracil—Graves' disease	0.00039	0.0206	CcSEcCtD
Nitrazepam—GABRG3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00039	0.00375	CbGpPWpGaD
Nitrazepam—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.000388	0.00374	CbGpPWpGaD
Nitrazepam—GABRA4—pituitary gland—Graves' disease	0.000388	0.0525	CbGeAlD
Nitrazepam—GABRP—pituitary gland—Graves' disease	0.000385	0.0521	CbGeAlD
Nitrazepam—GABRB1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000384	0.00369	CbGpPWpGaD
Nitrazepam—GABRR1—Neuronal System—GABRA3—Graves' disease	0.00038	0.00366	CbGpPWpGaD
Nitrazepam—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.000377	0.00363	CbGpPWpGaD
Nitrazepam—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000364	0.0035	CbGpPWpGaD
Nitrazepam—GABRA6—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000363	0.0035	CbGpPWpGaD
Nitrazepam—GABRR2—Neuronal System—GABRA3—Graves' disease	0.000363	0.00349	CbGpPWpGaD
Nitrazepam—GABRQ—Neuronal System—GABRA3—Graves' disease	0.000363	0.00349	CbGpPWpGaD
Nitrazepam—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.000362	0.00348	CbGpPWpGaD
Nitrazepam—GABRA4—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000359	0.00345	CbGpPWpGaD
Nitrazepam—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000355	0.00342	CbGpPWpGaD
Nitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000349	0.00336	CbGpPWpGaD
Nitrazepam—GABRA3—thyroid gland—Graves' disease	0.000343	0.0464	CbGeAlD
Nitrazepam—GABRB3—eye—Graves' disease	0.000336	0.0454	CbGeAlD
Nitrazepam—Diazepam—GABRA3—Graves' disease	0.000335	0.0461	CrCbGaD
Nitrazepam—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000328	0.00316	CbGpPWpGaD
Nitrazepam—GABRG2—pituitary gland—Graves' disease	0.000325	0.0439	CbGeAlD
Nitrazepam—GABRB3—connective tissue—Graves' disease	0.000324	0.0438	CbGeAlD
Nitrazepam—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000319	0.00307	CbGpPWpGaD
Nitrazepam—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.00031	0.00299	CbGpPWpGaD
Nitrazepam—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000307	0.00296	CbGpPWpGaD
Nitrazepam—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000305	0.00294	CbGpPWpGaD
Nitrazepam—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.0003	0.00289	CbGpPWpGaD
Nitrazepam—GABRG3—Neuronal System—GABRA3—Graves' disease	0.000299	0.00287	CbGpPWpGaD
Nitrazepam—GABRA2—adipose tissue—Graves' disease	0.000295	0.0399	CbGeAlD
Nitrazepam—GABRB1—Neuronal System—GABRA3—Graves' disease	0.000294	0.00283	CbGpPWpGaD
Nitrazepam—GABRE—pituitary gland—Graves' disease	0.000294	0.0398	CbGeAlD
Nitrazepam—GABRE—adipose tissue—Graves' disease	0.000293	0.0396	CbGeAlD
Nitrazepam—GABRA6—Neuronal System—GABRA3—Graves' disease	0.000278	0.00268	CbGpPWpGaD
Nitrazepam—GABRA4—Neuronal System—GABRA3—Graves' disease	0.000275	0.00264	CbGpPWpGaD
Nitrazepam—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000262	0.00252	CbGpPWpGaD
Nitrazepam—GABRE—thyroid gland—Graves' disease	0.000254	0.0343	CbGeAlD
Nitrazepam—GABRB2—Neuronal System—GABRA3—Graves' disease	0.000251	0.00242	CbGpPWpGaD
Nitrazepam—GABRB3—pituitary gland—Graves' disease	0.000249	0.0337	CbGeAlD
Nitrazepam—GABRA5—Neuronal System—GABRA3—Graves' disease	0.000244	0.00235	CbGpPWpGaD
Nitrazepam—GABRA2—Neuronal System—GABRA3—Graves' disease	0.000236	0.00227	CbGpPWpGaD
Nitrazepam—GABRB3—Neuronal System—GABRA3—Graves' disease	0.000234	0.00225	CbGpPWpGaD
Nitrazepam—GABRG2—Neuronal System—GABRA3—Graves' disease	0.00023	0.00221	CbGpPWpGaD
Nitrazepam—GABRB3—thyroid gland—Graves' disease	0.000215	0.0291	CbGeAlD
Nitrazepam—GABRR1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000204	0.00197	CbGpPWpGaD
Nitrazepam—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000201	0.00193	CbGpPWpGaD
Nitrazepam—GABRR2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000195	0.00188	CbGpPWpGaD
Nitrazepam—GABRQ—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000195	0.00188	CbGpPWpGaD
Nitrazepam—GABRG3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000161	0.00155	CbGpPWpGaD
Nitrazepam—GABRB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000158	0.00152	CbGpPWpGaD
Nitrazepam—GABRA6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00015	0.00144	CbGpPWpGaD
Nitrazepam—GABRA4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000148	0.00142	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—HLA-E—Graves' disease	0.000138	0.00133	CbGpPWpGaD
Nitrazepam—CYP2E1—thyroid gland—Graves' disease	0.000137	0.0185	CbGeAlD
Nitrazepam—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000135	0.0013	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—CD40—Graves' disease	0.000135	0.0013	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—CTLA4—Graves' disease	0.000133	0.00128	CbGpPWpGaD
Nitrazepam—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000131	0.00126	CbGpPWpGaD
Nitrazepam—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000127	0.00122	CbGpPWpGaD
Nitrazepam—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000126	0.00121	CbGpPWpGaD
Nitrazepam—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000124	0.00119	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	0.00011	0.00105	CbGpPWpGaD
Nitrazepam—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000108	0.00104	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—HLA-B—Graves' disease	9.84e-05	0.000948	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—FASLG—Graves' disease	9.62e-05	0.000926	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—FAS—Graves' disease	9.28e-05	0.000893	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—IL2RA—Graves' disease	9.22e-05	0.000888	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—HLA-A—Graves' disease	9.12e-05	0.000878	CbGpPWpGaD
Nitrazepam—ABCB1—pituitary gland—Graves' disease	9.03e-05	0.0122	CbGeAlD
Nitrazepam—ABCB1—adipose tissue—Graves' disease	9e-05	0.0122	CbGeAlD
Nitrazepam—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	8.33e-05	0.000802	CbGpPWpGaD
Nitrazepam—ABCB1—thyroid gland—Graves' disease	7.79e-05	0.0105	CbGeAlD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	6.28e-05	0.000604	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—IFNG—Graves' disease	6.09e-05	0.000586	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—IL1B—Graves' disease	5.43e-05	0.000523	CbGpPWpGaD
Nitrazepam—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	5.42e-05	0.000522	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	4.75e-05	0.000457	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	4.58e-05	0.000441	CbGpPWpGaD
Nitrazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	4.56e-05	0.000439	CbGpPWpGaD
Nitrazepam—ABCB1—Allograft Rejection—TNF—Graves' disease	3.94e-05	0.000379	CbGpPWpGaD
Nitrazepam—SCN1A—Developmental Biology—TNF—Graves' disease	3.91e-05	0.000377	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—GC—Graves' disease	3.62e-05	0.000349	CbGpPWpGaD
Nitrazepam—CYP2E1—Metabolism—B3GNT2—Graves' disease	2.75e-05	0.000264	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—GC—Graves' disease	2.73e-05	0.000263	CbGpPWpGaD
Nitrazepam—ABCB1—Metabolism—B3GNT2—Graves' disease	2.07e-05	0.000199	CbGpPWpGaD
Nitrazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	1.94e-05	0.000187	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—GC—Graves' disease	1.68e-05	0.000162	CbGpPWpGaD
Nitrazepam—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.27e-05	0.000123	CbGpPWpGaD
